Advertisement

Topics

Arrowhead Publishers Company Profile

01:00 EST 16th December 2018 | BioPortfolio

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis and forecasting that is essential in today’s ultra-competitive pharmaceutical and biotech markets.

Arrowhead analysts draw upon the most up-to-date information and lend their industry expertise to market reports which assess the state of burgeoning pharmaceutical and biotech markets.

Our reports not only provide the most up-to-date market figures, forecasts, and pipeline data, but offer valuable analysis regarding successes and failures in the ever-competitive healthcare industry. Arrowhead reports blend information and analysis concerning clinical trials, industry trends, and market dynamics to come to determinations about the future of of the pharmaceutical and biotech industries.

Our market reports are designed with the time-sensitive executive in mind and include a large number of graphs and tables which illustrate trends and forecasts that are integral to an understanding of the global healthcare market.

Location

5412 Irvimg Avenue South
Minneapolis
Minnesota
55419
United States of America

Contact

Phone: 1-312-244-3703
Fax: 1-312-244-3703
Email: sales@arrowheadpublisher.net


News Articles [210 Associated News Articles listed on BioPortfolio]

J&J Bets Big On Arrowhead’s Early Promise In Hepatitis B

The pharma is paying $250m up front for worldwide rights to Arrowhead’s Phase I/II RNAi candidate. Arrowhead says letting J&J...   

Arrowhead refills its quiver

Arrowhead’s RNAi toxicity setback in 2016 gave it a jumpstart on a safer and more versatile platform.

Janssen Reaches $250M Deal for Rights to Arrowhead’s Hep B RNAi Drug

Arrowhead Pharmaceuticals is licensing one of its drug candidates, a hepatitis B treatment, to a subsidiary of pharmaceutical giant Johnson & Johnson in a cash and stock deal valued at $250 millio...

Arrowhead, Janssen sign $3.7bn license and collaboration deal

ARO-HBV is the third generation subcutaneously administered RNA interference (RNAi) therapeutic of Arrowhead being developed as a potential curative therapy for patients with chronic HBV infection. Th...

Arrowhead, Janssen pen deal worth up to $3.7bn

In a deal potentially worth $3.7bn, Arrowhead Pharmaceuticals Inc. licensed Janssen Pharmaceuticals Inc. exclusive worldwide rights to develop and commercialize its ARO-HBV program. In addition, Janss...

Arrowhead ends enrolment in AROAAT1001 trial

Arrowhead Pharmaceuticals has completed patient enrolment in the Phase l AROAAT1001 trial of ARO-AAT for Treatment of Alpha-1 Liver Disease....Read More... The post Arrowhead ends enrolment in AROAAT1...

Janssen signs $3.7bn licence agreements with Arrowhead

Janssen Pharmaceuticals has signed a $3.7bn licence and collaboration agreement with Arrowhead Pharmaceuticals for the development and commercialisation of a...Read More... The post Janssen signs $3.7...

Arrowhead reports on initial data from RNAi therapy study for HBV

Arrowhead Pharmaceuticals' third-generation RNA interference therapy candidate ARO-HBV decreased circulating hepatitis B viru -More- 

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Arimidex [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use ARIMIDEX safely and effectively. See full prescribing information for ARIMIDEX. Initial U.S. Approval: 1995

Arimidex [AstraZeneca Pharmaceuticals LP]

These highlights do not include all the information needed to use ARIMIDEX safely and effectively. See full prescribing information for ARIMIDEX. ARIMIDEX® (anastrozole) tablet for oral use Initial U...

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

A data citation roadmap for scientific publishers.

This article presents a practical roadmap for scholarly publishers to implement data citation in accordance with the Joint Declaration of Data Citation Principles (JDDCP), a synopsis and harmonization...

All publishers are predatory - some are bigger than others.

Predatory Open-Access Medical Publishers: "Caveat Emptor".

Predatory Open-Access Publishing in Anesthesiology.

Predatory publishing is an exploitative fraudulent open-access publishing model that applies charges under the pretense of legitimate publishing operations without actually providing the editorial ser...

An analysis of retractions of papers authored by Scott Reuben, Joachim Boldt and Yoshitaka Fujii.

We analysed how long it has taken for papers authored by Scott Reuben, Joachim Boldt and Yoshitaka Fujii to be retracted: investigations into these three anaesthetists have shown much of their researc...

Clinical Trials [0 Results]

None

Companies [97 Associated Companies listed on BioPortfolio]

Arrowhead Publishers & Conferences

Arrowhead Publishers and Conferences

Arrowhead Publishers

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis...

Arrowhead Research Corporation

Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronic...

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes...

More Information about "Arrowhead Publishers" on BioPortfolio

We have published hundreds of Arrowhead Publishers news stories on BioPortfolio along with dozens of Arrowhead Publishers Clinical Trials and PubMed Articles about Arrowhead Publishers for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arrowhead Publishers Companies in our database. You can also find out about relevant Arrowhead Publishers Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record